Inventor · disambiguated record
Luigi Moro
Also filed as: MORO LUIGI
36 granted patents·26 pending applications·348 citations·filing 1980–2025
97Inventor score
Files withCOSMO TECHNOLOGIES LTD30CASSIOPEA S P A12POLI IND CHIMICA SPA4AJANI MAURO3COSMO TECH LIMITED3
Top patents by PatentIndex Score
62 records- 0195US9364580B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2015·Granted Jun 14, 2016·17 cites·24 claims
- 0294US9486458B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2015·Granted Nov 8, 2016·10 cites·24 claims
- 0394US9226996B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Jan 5, 2016·23 cites·14 claims
- 0494US8143240B217α, 21-dihydroxypregnene esters as antiandrogenic agentsAJANI MAURO·Filed 2009·Granted Mar 27, 2012·18 cites·9 claims
- 0593US10166245B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2016·Granted Jan 1, 2019·7 cites·34 claims
- 0693US10159682B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2016·Granted Dec 25, 2018·7 cites·20 claims
- 0793US9522216B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Dec 20, 2016·12 cites·24 claims
- 0893US2025387412A1Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2025·Application pending·0 cites
- 0992US8545811B2Solid composition for the oral administration of dyes and diagnostic use thereofMORO LUIGI·Filed 2012·Granted Oct 1, 2013·15 cites·22 claims
- 1090US8865690B217alfa, 21-dihydroxypregnene esters as antiandrogenic agentsCOSMO DERMATOS SRL·Filed 2013·Granted Oct 21, 2014·13 cites·10 claims
- 1189US9433628B2Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2013·Granted Sep 6, 2016·6 cites·24 claims
- 1287US12337002B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2022·Granted Jun 24, 2025·0 cites·21 claims
- 1387US9895379B217alpha, 21-dihydroxypregnene esters as antiandrogenic agentsCASSIOPEA S P A·Filed 2015·Granted Feb 20, 2018·4 cites·15 claims
- 1486US9211295B217 alpha, 21-dihydroxypregnene esters as antiandrogenic agentsCASSIOPEA S P A·Filed 2014·Granted Dec 15, 2015·5 cites·26 claims
- 1585US9962445B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted May 8, 2018·3 cites·20 claims
- 1683US10413611B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2018·Granted Sep 17, 2019·2 cites·15 claims
- 1782US11938141B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2021·Granted Mar 26, 2024·0 cites·12 claims
- 1882US9987366B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Jun 5, 2018·3 cites·49 claims
- 1980US12036316B2Oral rifamycin SV compositionsCOSMO TECHNOLOGIES LTD·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 2080US2024398699A1Oral rifamycin sv compositionsCOSMO TECHNOLOGIES LTD·Filed 2024·Application pending·0 cites
- 2179US2023130628A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2022·Application pending·0 cites
- 2278US10849979B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2019·Granted Dec 1, 2020·0 cites·20 claims
- 2378US10716796B2Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2018·Granted Jul 21, 2020·0 cites·15 claims
- 2477US8642082B2Pharmaceutical compositions for the oral administration of heparin or derivatives thereofAJANI MAURO·Filed 2002·Granted Feb 4, 2014·10 cites·11 claims
- 2577US4460577APharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making sameERBA FARMITALIA·Filed 1980·Granted Jul 17, 1984·38 cites·12 claims
- 2676US2020268909A1Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 2775US11207332B2Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivativesCASSIOPEA S P A·Filed 2019·Granted Dec 28, 2021·0 cites·20 claims
- 2873US2020129643A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 2972US2020163888A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECH LIMITED·Filed 2019·Application pending·0 cites
- 3071US2025186626A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2025·Application pending·0 cites
- 3170US9402923B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2013·Granted Aug 2, 2016·0 cites·19 claims
- 3269US11564883B2Oral rifamycin SV compositionsCOSMO TECHNOLOGIES LTD·Filed 2018·Granted Jan 31, 2023·0 cites·18 claims
- 3369US9402922B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2013·Granted Aug 2, 2016·0 cites·28 claims
- 3468US11123460B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2019·Granted Sep 21, 2021·0 cites·19 claims
- 3568US5759566AMicroemulsion pharmaceutical compositions for the delivery of pharmaceutically active agentsPOLI IND CHIMICA SPA·Filed 1996·Granted Jun 2, 1998·32 cites·25 claims
- 3668US2015283268A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 3766US5654000APharmaceutical compositions for transmucosal delivery of peptidesPOLI IND CHIMICA SPA·Filed 1996·Granted Aug 5, 1997·28 cites·13 claims
- 3866US5066495AProcesses for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related productsPOLI IND CHIMICA SPA·Filed 1990·Granted Nov 19, 1991·46 cites·8 claims
- 3964US2016303141A1CORTEXOLONE 17alpha-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERSCASSIOPEA S P A·Filed 2014·Application pending·0 cites
- 4064US2015010639A1Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disordersCOSMO TECHNOLOGIES LTD·Filed 2014·Application pending·0 cites
- 4161US4499066APharmaceutical sustained-release compositionsERBA FARMITALIA·Filed 1982·Granted Feb 12, 1985·22 cites·10 claims
- 4260US2018214580A1Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2018·Application pending·0 cites
- 4359US2014187517A1Method for treating intestinal diseases presenting at least one inflammatory componentSANTARUS INC·Filed 2014·Application pending·0 cites
- 4459US2012149671A117alpha, 21-dihydroxypregnene esters as antiandrogenic agentsAJANI MAURO·Filed 2012·Application pending·0 cites
- 4558US10265420B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Apr 23, 2019·0 cites·27 claims
- 4658US2007128266A1Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disordersCOSMO TECHNOLOGIES LTD·Filed 2005·Application pending·0 cites
- 4758US2020061212A1Solid oral composition containing dyesCOSMO TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 4858US2013209559A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 4958US2018147301A1Solid oral composition containing dyesCOSMO TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 5058US2013225537A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Luigi Moro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →